Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With Alpha-1 Antitrypsin Deficiency–Associated Liver Disease Post author:GIBoardReview.com Post published: May 27, 2026 Post category:Society Guidelines You Might Also Like A multidisciplinary approach to the diagnosis and management of Wilson disease: 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases December 10, 2022 AGA Clinical Practice Update on Advances in Per-Oral Endoscopic Myotomy (POEM) and Remaining Questions — What We Have Learned in the Past Decade: Expert Review December 20, 2024 AGA Clinical Practice Guideline on Management of Gastroparesis October 9, 2025
A multidisciplinary approach to the diagnosis and management of Wilson disease: 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases December 10, 2022
AGA Clinical Practice Update on Advances in Per-Oral Endoscopic Myotomy (POEM) and Remaining Questions — What We Have Learned in the Past Decade: Expert Review December 20, 2024